Heidelberg Pharma AG
XETRA:HPHA

Watchlist Manager
Heidelberg Pharma AG Logo
Heidelberg Pharma AG
XETRA:HPHA
Watchlist
Price: 2.91 EUR -1.02%
Updated: May 28, 2024

Balance Sheet

Balance Sheet Decomposition
Heidelberg Pharma AG

Current Assets 48.1m
Cash & Short-Term Investments 32.6m
Receivables 3.3m
Other Current Assets 12.2m
Non-Current Assets 13.6m
PP&E 3.7m
Intangibles 8.9m
Other Non-Current Assets 974.8k
Current Liabilities 16.5m
Accounts Payable 5.1m
Short-Term Debt 5.1m
Other Current Liabilities 6.3m
Non-Current Liabilities 69.8k
Long-Term Debt 69.8k

Balance Sheet
Heidelberg Pharma AG

Rotate your device to view
Balance Sheet
Currency: EUR
Nov-2015 Nov-2016 Nov-2017 Nov-2018 Nov-2019 Nov-2020 Nov-2021 Nov-2022 Nov-2023
Assets
Cash & Cash Equivalents
1
5
30
19
10
5
6
81
43
Cash Equivalents
1
5
30
19
10
5
6
81
43
Total Receivables
0
0
0
1
1
2
1
1
2
Accounts Receivables
0
0
0
0
1
1
1
1
1
Other Receivables
0
0
0
0
0
0
0
0
1
Inventory
0
0
0
0
0
0
1
5
10
Other Current Assets
0
0
0
0
0
1
1
1
0
Total Current Assets
2
5
31
20
12
8
9
88
57
PP&E Net
1
1
1
2
2
3
4
4
4
PP&E Gross
1
1
1
2
2
3
4
4
4
Accumulated Depreciation
3
3
3
4
4
5
6
6
7
Intangible Assets
3
3
3
3
3
3
3
3
3
Goodwill
6
6
6
6
6
6
6
6
6
Note Receivable
0
0
0
0
0
0
0
0
1
Long-Term Investments
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
Other Assets
6
6
6
6
6
6
6
6
6
Total Assets
12
N/A
15
+26%
41
+172%
31
-25%
23
-26%
20
-15%
22
+11%
101
+363%
70
-30%
Liabilities
Accounts Payable
0
0
2
0
1
3
1
3
8
Accrued Liabilities
2
1
2
3
3
3
3
4
1
Short-Term Debt
0
4
0
0
0
0
10
16
6
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
Other Current Liabilities
1
0
1
2
2
0
0
5
5
Total Current Liabilities
3
5
4
5
6
7
15
28
20
Long-Term Debt
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
6
1
Total Liabilities
3
N/A
5
+109%
4
-19%
5
+19%
7
+26%
7
+0%
15
+123%
34
+126%
21
-38%
Equity
Common Stock
9
13
22
28
28
31
34
47
47
Retained Earnings
184
191
202
213
222
240
266
285
302
Additional Paid In Capital
185
188
216
210
210
222
238
305
305
Other Equity
0
0
0
0
0
0
0
0
0
Total Equity
9
N/A
10
+3%
37
+279%
26
-30%
16
-37%
13
-21%
7
-48%
67
+895%
49
-26%
Total Liabilities & Equity
12
N/A
15
+26%
41
+172%
31
-25%
23
-26%
20
-15%
22
+11%
101
+363%
70
-30%
Shares Outstanding
Common Shares Outstanding
10
13
22
28
28
31
34
47
47

See Also

Discover More